Literature DB >> 7997731

Gynecological sarcomas.

P J DiSaia1, S Pecorelli.   

Abstract

Sarcomas of the uterus, ovary and lower genital tract are fortunately rare, since the prognosis is quite often poor. The most frequent are sarcomas of the uterine corpus, and these account for only 4% of all uterine tumors. Ovarian sarcomas are less frequent, and the prognosis is even poorer when compared to the uterus. Sarcoma of the lower genital tract (vagina and vulva) in adults is often published as a case report, given their very infrequent occurrence.

Entities:  

Mesh:

Year:  1994        PMID: 7997731     DOI: 10.1002/ssu.2980100510

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  6 in total

1.  "Cutaneous-type" angiosarcoma arising in a mature cystic teratoma of the ovary.

Authors:  M A den Bakker; A C Ansink; P C Ewing-Graham
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

2.  Smooth muscle neoplasms of the vulva masquerading as Bartholin gland duct cysts.

Authors:  Rebecca A Levy; Whitney M Winham; Christopher S Bryant; Charles M Quick
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-01

Review 3.  Uterine sarcoma 2008.

Authors:  Jeff F Lin; Brian M Slomovitz
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

4.  Ovarian angiosarcoma: a case report and review of the literature.

Authors:  Nausheen Yaqoob; Dalal Nemenqani; Hatem Khoja; Moemen Hafez; Asma Tulbah; Fuoad Al-Dayel
Journal:  J Med Case Rep       Date:  2014-02-12

5.  Proposed novel nomenclature of vulvar smooth muscle tumors; a case of Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) of the vulva.

Authors:  Mathieu Viau; Marie Plante; Marie-Claude Renaud; Katherine Grondin; Chantale Morin
Journal:  Gynecol Oncol Rep       Date:  2017-01-19

6.  Leiomyosarcoma of the vulva: a case report.

Authors:  Angel Yordanov; Stanislav Slavchev; Stoyan Kostov; Strahil Strashilov; Ivan Ivanov; Margarita Nikolova
Journal:  Prz Menopauzalny       Date:  2021-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.